DENNIS STEPHEN POE
Pilots at Tirrell Cres, Boston, MA

License number
Massachusetts A2301362
Issued Date
Jul 2015
Expiration Date
Jul 2017
Category
Airmen
Type
Authorized Aircraft Instructor
Address
Address
30 Tirrell Cres, Boston, MA 02467

Professional information

Dennis S Poe Photo 1

Dr. Dennis S Poe, Boston MA - MD (Doctor of Medicine)

Specialties:
Neurotology
Address:
CHILDRENS HOSPITAL BOSTON
300 Longwood Ave, Boston 02115
(617) 355-6000 (Phone)
Childrens Hosp Bostn Otolrnglgy
300 Longwood Ave SUITE LO-367, Boston 02115
(617) 355-6460 (Phone)
Certifications:
Neurotology, 2004, Otolaryngology, 1987
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
SUNY Upstate Med Univ
Graduated: 1982
Umass Med Center
Universitiy Chicago Med Center
Graduated: 1987
University Ma Med Center
Graduated: 1983
Otology Group
Graduated: 1988


Dennis S Poe Photo 2

Dennis S Poe, Boston MA

Specialties:
Ear, Nose & Throat Doctor
Address:
333 Longwood Ave, Boston, MA 02115
300 Longwood Ave, Boston, MA 02115
Education:
State University of New York, Upstate Medical University - Doctor of Medicine
Bernard Mitchell Hospital-University of Chicago Hospitals - Residency - Otolaryngology-Head and Neck Surgery
UMass Memorial Medical Center - Memorial Campus - Residency - Surgery
Board certifications:
American Board of Otolaryngology Certification in Otolaryngology, American Board of Otolaryngology Sub-certificate in Neurotology (Otolaryngology)


Dennis Poe Photo 3

Treatments For Immune-Mediated Ear Disorders

US Patent:
2004007, Apr 15, 2004
Filed:
Apr 15, 2003
Appl. No.:
10/414259
Inventors:
Mahboob Rahman - Sharon MA, US
Dennis Poe - Chestnut Hill MA, US
Hyon Choi - Lexington MA, US
International Classification:
A61K031/42
US Classification:
514/378000
Abstract:
Disclosed herein are methods for treating immune-mediated ear disorders, such as IMCVDs, or their symptoms, involving administration of a therapeutically-effective amount of a TNF antagonist, such as etanercept or infliximab, or a therapeutically-effective amount of a pyrimidine synthesis inhibitor, such as leflunomide.


Dennis Poe Photo 4

Treatments For Immune-Mediated Ear Disorders

US Patent:
2002004, Apr 18, 2002
Filed:
Mar 27, 2001
Appl. No.:
09/818411
Inventors:
Mahboob Rahman - Sharon MA, US
Dennis Poe - Chestnut Hill MA, US
Hyon Choi - Lexington MA, US
International Classification:
A61K038/19
US Classification:
424/085100
Abstract:
Disclosed herein are methods for treating immune-mediated ear disorders, such as IMCVDs, or their symptoms, involving administration of a therapeutically-effective amount of a TNF antagonist, such as etanercept or infliximab, or a therapeutically-effective amount of a pyrimidine synthesis inhibitor, such as leflunomide.